Please assess the completion status of the following clinical trial:

Trial Title: Effect of Losartan in Patients With Nonobstructive Hypertrophic Cardiomyopathy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with hypertrophic cardiomyopathy~* Left ventricular outflow tract (LVOT) gradient less than 30 mm Hg at rest~* Age 18 years or older~Exclusion Criteria:~* Contraindication to losartan~* Already taking losartan~* Contraindication to MRI~* Hemodynamic instability

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- losartan (Type: EXPERIMENTAL): Losartan 50 mg b.i.d.
- placebo (Type: PLACEBO_COMPARATOR): Placebo b.i.d.

Based on this trial design, predict the completion outcome and termination type (if applicable).